Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Eur Respir J. 2014 Oct 16;45(2):408–418. doi: 10.1183/09031936.00062914

TABLE 1.

Patient characteristics

Characteristics Comparative dataset Effect of O2
Effect of ACZ
Baseline O2 Baseline ACZ
Demographics
 Males/females n/n 19/9 9/2 7/5
 Age years 48±10 49±10 48±7
 Body mass index kg·m−2 35±6 34±7 34±7
 CPAP cmH2O 10.9±2.9 10.6±2.4 10.5±2.0
Sleep
 Time in bed min 416±37 403±41 402±30 428±40 413±39
 TST min 321±51 325±55 299±57 340±42 338±44
  Supine non-REM 261±63 273±60 243±65* 285±68 296±52
  Supine REM 28±17 37±24 35±30 32±14 30±11
Respiratory event characteristics
 AHI events·h−1 33 (32) 58 (56) 42 (38)* 48 (17) 25 (20)
  Supine non-REM 33 (37) 56 (55) 42 (43)* 50 (19) 24 (22)*
  REM/non-REM 1.18±0.83 1.09±0.84 1.38±0.92 0.94±0.38 1.30±1.10
  Obstructive apnoea index# events·h−1 2.1 (12.6) 31 (29) 16 (43) 4.86 (7.28) 0.63 (6.21)
  Mixed apnoea index# events·h−1 0.00 (0.53) 0.37 (4.55) 0.22 (0.60) 0.00 (0.65) 0.00 (0.04)
  Central apnoea index# events·h−1 0.00 (0.50) 0.39 (5.32) 0.00 (0.27)* 0.00 (0.16) 0.00 (0.00)
  Hypopnoea index# events·h−1 33 (22) 12 (14) 11 (11) 39 (24) 18 (15)
 Arousal index# events·h−1 41 (24) 60 (44) 51 (35) 39 (10) 32 (7)
 Mean O2 saturation# % 94±2 93±3 97±1* 94±1 95±2*
 Minimum O2 saturation# % 83±6 78±7 89±4* 82±4 85±5
 Stable breathing#,¶ % 18±18 14±17 14±16 10±12 20±17
 Event duration s 26±6 23±4 27±5* 30±10 36±10*
 Inter-event interval s 44±10 38±8 49±8* 49±13 61±14*
Ventilatory control
 Standard loop gain+ 0.57±0.21 0.46±0.26§ 0.32±0.06f 0.60±0.33 0.35±0.21*

Data are presented as mean±SDor median (interquartile range), unless otherwise stated. ACZ: acetazolamide; CPAP: continuous positive airway pressure; TST: total sleep time; REM: rapid eye movement; AHI: apnoea–hypopnoea index.

#

measured in supine non-REM sleep

stable breathing (no events or arousals for ≥5 min)

+

ratio of feedback response to a 1-cycle·min−1 oscillatory disturbance as measured using CPAP drops except for in the O2 study, when proportional ventilation was used in some individuals

§

proportional assist ventilation used in nine individuals

ƒ

proportional assist ventilation used in seven individuals.

*

p<0.05 versus baseline.